Clinical and economical efficiency and safety and inflammation parameter correlations study of conservative treatment of non-complicated acute appendicitis in 7 to 18 years old children.

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-520496-19-00

Enrollment

Registered

2025-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute non-complicated appendicitis in patients aged 7 to 18

Brief summary

3 days in-patient treatment; 7 days out-patient treatment

Detailed description

1 month follow-up; 1 year follow-up

Interventions

DRUGAmoksiklav 875 mg/125 mg apvalkotās tabletes

DRUGMetronidazole Unifarma 5 mg/ml škidums infuzijam

DRUGMedoclav 500 mg/125 mg apvalkotās tabletes

DRUGPamecil 1 g pulveris injekciju/infūziju šķīduma pagatavošanai

DRUGCeftazidime Fresenius Kabi 1000 mg pulveris injekciju šķīduma pagatavošanai

Eligibility

Sex/Gender

All

Age

0 Years to 17 Years

Design outcomes

Primary

Measure	Time frame
3 days in-patient treatment; 7 days out-patient treatment	—

Secondary

Measure	Time frame
1 month follow-up; 1 year follow-up	—

Countries

Latvia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026